OSAT yields 53.33% · MRK yields 2.76%● Live data
📍 OSAT pulled ahead of the other in Year 1
Combined, OSAT + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OSAT + MRK for your $10,000?
Orbsat Corp., together with its subsidiaries, provides mobile satellite services (MSS) solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and Internet of Things (IoT) connectivity services in the United States and internationally. Its solutions include satellite communications, IoT tracking, and Internet, as well as emergency locator beacons. The company also provides tracking and monitoring solutions using automatic identification system, 2G-5G, push-to-talk, and two-way radio technology; and sells MSS related equipment. In addition, it operates GTCTrack, a subscription-based mapping and tracking portal that provides cloud-based data visualization and management platform that allow managers to track, command, and control assets in near-real-time; and a short-term rental service for customers to use equipment for a limited time period. The company provides its solutions for businesses, governments, military, humanitarian organizations, and individual users to communicate, connect to internet, track and monitor remote assets and lone workers, or request SOS assistance via satellite. It offers its products and services directly to end users and reseller networks; operates e-commerce websites that offer a range of MSS products and solutions; and offers portable satellite voice, data, and tracking solutions through various third-party e-commerce storefronts. The company was formerly known as Orbital Tracking Corp and changed its name to Orbsat Corp. in August 2019. Orbsat Corp. was incorporated in 1997 and is headquartered in Aventura, Florida.
Full OSAT Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.